Multicenter, Randomized, Placebo-controlled, Double-blind, Parallelgroup Proof-of-concept Study of Lixisenatide in Patients with Early Parkinson's Disease (PD): the LIXIPARK Trial (NCT03439943)
MOVEMENT DISORDERS(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined